K. Hoffman

发表

Structural identification of SAR-943 metabolites generated by human liver microsomes in vitro using mass spectrometry in combination with analysis of fragmentation patterns.

T. Strom, T. Shokati, J. Klawitter, 2011, Journal of mass spectrometry : JMS.

Comparison of the quantification of acetaminophen in plasma, cerebrospinal fluid and dried blood spots using high-performance liquid chromatography-tandem mass spectrometry.

K. Hoffman, U. Christians, Rachel R. Taylor, 2013, Journal of pharmaceutical and biomedical analysis.

Continuous administration of a selective α7 nicotinic partial agonist, DMXBA, improves sensory inhibition without causing tachyphylaxis or receptor upregulation in DBA/2 mice

K. Hoffman, U. Christians, C. Adams, 2010, Brain Research.

Elimination of "hook-effect" in two-site immunoradiometric assays by kinetic rate analysis.

J. M. Brooks, K. Hoffman, G. Parsons, 1984, Clinical chemistry.

Tandem-in-time mass spectrometry as a quantitative bioanalytical tool.

T. D. Parker, K. Hoffman, D. T. Rossi, 1997, Analytical chemistry.

A low blood volume LC-MS/MS assay for the quantification of fentanyl and its major metabolites norfentanyl and despropionyl fentanyl in children.

K. Hoffman, U. Christians, B. Schniedewind, 2011, Journal of separation science.

A sensitive assay for the quantification of morphine and its active metabolites in human plasma and dried blood spots using high-performance liquid chromatography–tandem mass spectrometry

K. Hoffman, U. Christians, B. Carvalho, 2011, Analytical and bioanalytical chemistry.

Quantification of the 5-lipoxygenase inhibitor zileuton in human plasma using high performance liquid chromatography-tandem mass spectrometry.

K. Hoffman, U. Christians, P. Malik, 2013, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Semi-automated 96-well liquid-liquid extraction for quantitation of drugs in biological fluids.

K. Hoffman, D. T. Rossi, N. Zhang, 2000, Journal of pharmaceutical and biomedical analysis.

Influence of SLCO1B1 Polymorphisms on the Drug‐Drug Interaction Between Darunavir/Ritonavir and Pravastatin

K. Hoffman, U. Christians, C. Aquilante, 2012, Journal of clinical pharmacology.

Development of a chiral HPLC method to evaluate in vivo enantiomeric inversion of an unstable, polar radiosensitizer in plasma.

K. Hoffman, C. Lathia, D. T. Rossi, 1999, Journal of Pharmaceutical and Biomedical Analysis.

An HPLC assay utilizing solid-phase extraction for CI-1010, an alkylating radiosensitizer, in rat plasma.

K. Hoffman, C. Lathia, D. T. Rossi, 1997, Journal of pharmaceutical and biomedical analysis.

Influence of SLCO1B1 Polymorphisms on the Drug‐Drug Interaction Between Darunavir/Ritonavir and Pravastatin

K. Hoffman, U. Christians, C. Aquilante, 2012, Journal of clinical pharmacology.